|Available-for-sale financial assets comprise the Group's holding
of Novo Nordisk B stock, which has been acquired with a view to hedging the
stock option obligation, cf. Note 24. The holding has been stated as current
assets. A loss of DKK 15 million on market value adjustment has been
recognized in Shareholders' equity in 2008, and DKK 38 million has been
transferred from Shareholders' equity to Financial income relating to
realization of stock. In 2007 the market value adjustment was DKK 40 million,
and DKK 35 million was transferred to Financial income.